Nuclear plant worker’s cancer judged not to be a work-related illness
The Federal Court has dismissed the appeal of a former employee of two Swiss nuclear power plants who was diagnosed with bladder and prostate cancer. The man took legal action after the national accident insurance fund refused benefits for an occupational illness.
This content was published on
1 minute
Keystone-SDA/ts
The now 52-year-old man worked at the Leibstadt nuclear power plant in 2003 and 2004. In 2010 he worked as an expert for the Swiss Association for Technical Inspections at Mühleberg nuclear power plant.
More
More
Swiss nuclear power station restarted
This content was published on
The Leibstadt nuclear power station is being put back into operation after it was shut down on Saturday due to a technical fault.
After he was diagnosed with cancer, in 2016 he applied to the Swiss National Accident Insurance Fund (SUVA) for benefits on account of a work-related illness.
SUVA refused, and the man came before the Federal Court for the first time last year. The court overturned an initial unfavourable ruling against him, finding that the expert opinion commissioned by the man cast doubt on the conclusions of the SUVA occupational doctor. The court ordered a multidisciplinary judicial expert opinion.
In July this year, the social insurance court of canton Zurich again rejected the man’s appeal. It based its decision on an expert opinion by a professor emeritus from Munich, a specialist in radiobiology.
According to the expert opinion, occupational radiation exposure would have had to be more than 500 times higher to achieve a 50% probability of causing bladder cancer. In the case of prostate cancer, the factor was at least 1,500.
The Federal Court supported this view in a ruling published on Wednesday.
More
More
Pills to take in a nuclear accident
This content was published on
Every ten years the Swiss government distributes potassium iodide tablets to people living near nuclear plants, but how effective are they? (SRF, swissinfo.ch)
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
This content was published on
If there were a serious accident at one of Switzerland’s nuclear reactors, many of the radiation victims would be residents of other countries.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.